Stocks News

LAST PRICE
54.8000
TODAY'S CHANGE (%)
Trending Up1.9200 (3.6309%)

Bid / Lots
39.0000/ 1
Ask / Lots
58.5000/ 13
Open / Previous Close
53.0200 / 52.8800
Day Range
Low 51.8042
High 56.4500
52 Week Range
Low 12.4500
High 67.2100
Volume
140,175
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Apr 26, 2024
- DJ Praxis Precision Med Price Target Maintained With a $105.00/Share by HC Wainwright & Co., from 7:16AM ET on Friday Apr 26, 2024 by Dow Jones
  7:16AM ET on Friday Apr 26, 2024 by Dow Jones
  Companies Mentioned: PRAX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/PRAX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 26, 2024 07:16 ET (11:16 GMT)
Apr 12, 2024
- Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting, from 8:00AM ET on Friday Apr 12, 2024 by GlobeNewswire
  8:00AM ET on Friday Apr 12, 2024 by GlobeNewswire
  Companies Mentioned: PRAX
- Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting, from 8:00AM ET on Friday Apr 12, 2024 by Dow Jones
  8:00AM ET on Friday Apr 12, 2024 by Dow Jones
  Companies Mentioned: PRAX
  
  Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting
  
  Innovative design of ongoing Phase 3 clinical program expected to set precedent for future clinical trials in essential tremor
Apr 8, 2024
- --Wedbush Trims Price Target on Praxis Precision Medicines to $40 From $41 After $200 Million Secondary Offering, Maintains Neutral Rating, from 10:26AM ET on Monday Apr 08, 2024 by MT Newswires
  10:26AM ET on Monday Apr 08, 2024 by MT Newswires
  Companies Mentioned: PRAX
  10:26 AM EDT, 04/08/2024 (MT Newswires) -- Price: 51.07, Change: +0.81, Percent Change: +1.61 ...
Apr 5, 2024
- Praxis Precision Medicines to Participate in Upcoming April Conferences, from 9:00AM ET on Friday Apr 05, 2024 by GlobeNewswire
  9:00AM ET on Friday Apr 05, 2024 by GlobeNewswire
  Companies Mentioned: PRAX

Apr 25, 2024
- Lifshitz Law PLLC Announces Investigations of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX), Cassava Sciences, Inc. (NASDAQ:SAVA), GrafTech International Ltd. (NYSE:EAF), and Mobileye Global Inc. (NASDAQ:MBLY), from 10:52PM ET on Thursday Apr 25, 2024 by Accesswire
  10:52PM ET on Thursday Apr 25, 2024 by Accesswire
  Companies Mentioned: SAVA, EAF, AMLX, MBLY
Apr 24, 2024
- ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting, from 10:00AM ET on Wednesday Apr 24, 2024 by GlobeNewswire
  10:00AM ET on Wednesday Apr 24, 2024 by GlobeNewswire
  Companies Mentioned: ALXO
- Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Earnings Deluge, from 7:53AM ET on Wednesday Apr 24, 2024 by MT Newswires
  7:53AM ET on Wednesday Apr 24, 2024 by MT Newswires
  Companies Mentioned: MMC, TSLA, ENPH, VRT, BKR, CNTA
- Centessa Pharmaceuticals Prices Equity Offering at $9.25 Per ADS, from 4:47AM ET on Wednesday Apr 24, 2024 by MT Newswires
  4:47AM ET on Wednesday Apr 24, 2024 by MT Newswires
  Companies Mentioned: CNTA
Apr 23, 2024
- Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares, from 9:37PM ET on Tuesday Apr 23, 2024 by GlobeNewswire
  9:37PM ET on Tuesday Apr 23, 2024 by GlobeNewswire
  Companies Mentioned: CNTA
- Centessa Pharmaceuticals Eyes $100 Million in ADS Offering, from 6:00PM ET on Tuesday Apr 23, 2024 by MT Newswires
  6:00PM ET on Tuesday Apr 23, 2024 by MT Newswires
  Companies Mentioned: CNTA
- Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares, from 4:18PM ET on Tuesday Apr 23, 2024 by GlobeNewswire
  4:18PM ET on Tuesday Apr 23, 2024 by GlobeNewswire
  Companies Mentioned: CNTA
Apr 22, 2024
- Centessa Pharmaceutical Gets FDA's Approval to Begin Phase 1 Trial of Narcolepsy Drug Candidate, from 8:33AM ET on Monday Apr 22, 2024 by MT Newswires
  8:33AM ET on Monday Apr 22, 2024 by MT Newswires
  Companies Mentioned: CNTA
- SS Innovations International Announces Q1 2024 Company Updates, from 8:00AM ET on Monday Apr 22, 2024 by GlobeNewswire
  8:00AM ET on Monday Apr 22, 2024 by GlobeNewswire
  Companies Mentioned: SSII
- Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024, from 7:00AM ET on Monday Apr 22, 2024 by GlobeNewswire
  7:00AM ET on Monday Apr 22, 2024 by GlobeNewswire
  Companies Mentioned: CNTA

Praxis Precision Medicines Inc
NASDAQ:PRAXUnited States

Search Criteria

Apr 26, 2024

DJ Praxis Precision Med Price Target Maintained With a $105.00/Share by HC Wainwright & Co., from 7:16AM ET on Friday Apr 26, 2024 by Dow Jones

Apr 12, 2024

Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting, from 8:00AM ET on Friday Apr 12, 2024 by GlobeNewswire

Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting, from 8:00AM ET on Friday Apr 12, 2024 by Dow Jones

Apr 8, 2024

--Wedbush Trims Price Target on Praxis Precision Medicines to $40 From $41 After $200 Million Secondary Offering, Maintains Neutral Rating, from 10:26AM ET on Monday Apr 08, 2024 by MT Newswires

Apr 5, 2024

Praxis Precision Medicines to Participate in Upcoming April Conferences, from 9:00AM ET on Friday Apr 05, 2024 by GlobeNewswire

Peers Headlines

Apr 25, 2024

Lifshitz Law PLLC Announces Investigations of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX), Cassava Sciences, Inc. (NASDAQ:SAVA), GrafTech International Ltd. (NYSE:EAF), and Mobileye Global Inc. (NASDAQ:MBLY), from 10:52PM ET on Thursday Apr 25, 2024 by Accesswire

Apr 24, 2024

ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting, from 10:00AM ET on Wednesday Apr 24, 2024 by GlobeNewswire

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Earnings Deluge, from 7:53AM ET on Wednesday Apr 24, 2024 by MT Newswires

Centessa Pharmaceuticals Prices Equity Offering at $9.25 Per ADS, from 4:47AM ET on Wednesday Apr 24, 2024 by MT Newswires

Apr 23, 2024

Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares, from 9:37PM ET on Tuesday Apr 23, 2024 by GlobeNewswire

Centessa Pharmaceuticals Eyes $100 Million in ADS Offering, from 6:00PM ET on Tuesday Apr 23, 2024 by MT Newswires

Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares, from 4:18PM ET on Tuesday Apr 23, 2024 by GlobeNewswire

Apr 22, 2024

Centessa Pharmaceutical Gets FDA's Approval to Begin Phase 1 Trial of Narcolepsy Drug Candidate, from 8:33AM ET on Monday Apr 22, 2024 by MT Newswires

SS Innovations International Announces Q1 2024 Company Updates, from 8:00AM ET on Monday Apr 22, 2024 by GlobeNewswire

Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024, from 7:00AM ET on Monday Apr 22, 2024 by GlobeNewswire